Learning Center

Prescription digital therapeutics are FDA-authorized software programs that physicians prescribe as a form of treatment. They can help patients manage serious conditions ranging from opioid addiction to asthma to sleep disorders.

Prescription digital therapeutics can, for example, deliver cognitive behavioral therapy – brain training – to a patient with chronic insomnia. Programs to treat other chronic diseases like congestive heart failure, dementia and Alzheimer’s are in development. All activity occurs via a phone or laptop app.

Medical/Pharmacy Benefit Claims

Trade Groups

Industry funded lobbying groups for Digital Therapeutics software developers.

Publications

AMCP Letter in Support of Prescription Digital Therapeutics Act. AMCP. 2022, Apr 4.

Sens. Capito, Shaheen, Reps. McKingley, Thompson Introduce BiPartisan Access to Prescription Digital Therapeutics Act. 2022, Mar 10.

Regulating digital therapeutics for mental health: Opportunities, challenges, and the essential role of psychologists. Carl J R, Jones D J, Lindhiem O J, et al. Br J Clin Psychol. 2022, Jan. doi: 10.1111/bjc.12286

Role of digital therapeutics and the changing future of healthcare. Dang A, Arora D, Rane P. J Family Med Prim Care. 2020, May 31. doi: 10.4103/jfmpc.jfmpc_105_20.

Digital therapeutics and clinical pharmacology. Chung J. Transl Clin Pharmacol. 2019, Mar. doi: 10.12793/tcp.2019.27.1.6

Ensuring public trust in digital therapeutics: a pharmacopeial perspective. Journal of Managed Care + Specialty Pharmacy, 2021 Apr;27(4):533-535.

AMCP Partnership Forum: Digital Therapeutics—What Are They and Where Do They Fit in Pharmacy and Medical Benefits? Journal of Managed Care + Specialty Pharmacy, 2020 May;26(5):674-681.

Digital therapeutics in neurology. Abbadessa G, Brigo F, Clerico M, et al. J Neurol. 2022, Mar. doi: 10.1007/s00415-021-10608-4.

Digital Therapeutics in Parkinson’s Disease: Practical Applications and Future Potential. Ellis T D, Earhart G M. J Parkinsons Dis. 2021. doi: 10.3233/JPD-202407.